Steven Stein
Vermogen: 7 M $ op 31-05-2026
Vermogen: 7 M $ op 31-05-2026
Steven H. Stein bekleedt de functie van Chief Medical Officer & Executive Vice President bij Incyte Corp. Dr. Stein zit ook in de raad van bestuur van Kura Oncology, Inc. In zijn vorige loopbaan was Dr. Stein Vice President-Global Oncology bij GlaxoSmithKline (New Jersey), SVP-US Clinical Development & Medical Affairs bij Novartis Oncology, Inc. en Senior VP-US Clinical Development & Medical Affair bij Novartis Pharmaceuticals Corp. Dr. Stein behaalde een doctoraat aan de Universiteit van de Witwatersrand.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
INCYTE CORPORATION 0,04% | 02-07-2026 | 76.150 ( 0,04% ) | 7 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| INCYTE CORPORATION | Hoofd Techniek/Wetenschap/O&O | 02-03-2015 |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Consultant / Adviseur | - |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| REPARE THERAPEUTICS INC. | Directeur/Bestuurslid | 28-01-2026 |
| THESEUS PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 14-02-2024 |
| KURA ONCOLOGY, INC. | Directeur/Bestuurslid | 01-05-2023 |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 01-02-2015 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01-02-2015 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 10 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Kura Oncology, Inc.
Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
University of the Witwatersrand
University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline (New Jersey) | |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Repare Therapeutics, Inc.
Repare Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of novel cancer therapies | Health Technology |
Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and supplies drugs for cancer patients | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau